Erik Robinson

Study in Nature Reveals New Molecular Insight

Researchers at OHSU open new avenue for developing medications

PORTLAND, Ore.– New research reveals for the first time the atomic structures of a key molecular receptor in the brain, which opens the door for developing medications that could block activation of these receptors to address a variety of conditions, ranging from pain to high blood pressure to ea

Subscribe to Erik Robinson